Why does COVID-19 continue to spread despite mass vaccination?
作者信息
Zhang Shuo, Yang Zhen, Chen Zhen-Lin, Yue Shi-Jun, Zhang Sai, Tang Yu-Ping
机构信息
Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine, Xi'an, China.
School of Clinical Medicine (Guang'anmen Hospital), Beijing University of Chinese Medicine, Beijing, China.
出版信息
Front Public Health. 2022 Jul 25;10:938108. doi: 10.3389/fpubh.2022.938108. eCollection 2022.
Abstract
摘要
相似文献
1
Why does COVID-19 continue to spread despite mass vaccination?
Front Public Health. 2022 Jul 25;10:938108. doi: 10.3389/fpubh.2022.938108. eCollection 2022.
2
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.
Lancet. 2021 Mar 6;397(10277):875-877. doi: 10.1016/S0140-6736(21)00448-7. Epub 2021 Feb 18.
3
COVID-19 Vaccine Development to Vaccination.
J Nepal Health Res Counc. 2021 Jan 22;18(4):807-809. doi: 10.33314/jnhrc.v18i4.3351.
4
Key steps in our journey to a COVID-19 vaccine program.
Med J Aust. 2021 Apr;214(6):249-251.e1. doi: 10.5694/mja2.50978. Epub 2021 Mar 21.
5
The long road ahead for COVID-19 vaccination in Africa.
Lancet. 2021 Sep 4;398(10303):827-828. doi: 10.1016/S0140-6736(21)01967-X.
6
A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose.
Ann Intern Med. 2021 Apr;174(4):552-553. doi: 10.7326/M20-8060. Epub 2021 Jan 5.
7
Serbia begins paying citizens to receive a COVID-19 vaccine.
Lancet. 2021 May 15;397(10287):1793. doi: 10.1016/S0140-6736(21)01097-7.
8
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
9
Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
Med J Aust. 2021 Nov 1;215(9):427-432. doi: 10.5694/mja2.51263. Epub 2021 Oct 11.
10
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
引用本文的文献
1
Predicting COVID-19 severity in pediatric patients using machine learning: a comparative analysis of algorithms and ensemble methods.
Sci Rep. 2025 Aug 8;15(1):29118. doi: 10.1038/s41598-025-15366-1.
2
Eucalyptus Essential Oil Inhibits Cell Infection by SARS-CoV-2 Spike Pseudotyped Lentivirus.
Biomedicines. 2024 Aug 19;12(8):1885. doi: 10.3390/biomedicines12081885.
3
Unlocking insights: Navigating COVID-19 challenges and Emulating future pandemic Resilience strategies with strengthening natural immunity.
Heliyon. 2024 Jul 17;10(15):e34691. doi: 10.1016/j.heliyon.2024.e34691. eCollection 2024 Aug 15.
4
Effectiveness and safety of azvudine in COVID-19: A systematic review and meta-analysis.
PLoS One. 2024 Jun 13;19(6):e0298772. doi: 10.1371/journal.pone.0298772. eCollection 2024.
5
Evolving trend change during the COVID-19 pandemic.
Front Public Health. 2022 Sep 20;10:957265. doi: 10.3389/fpubh.2022.957265. eCollection 2022.
本文引用的文献
1
When and How Will the Epidemic of COVID-19 End?
Aging Dis. 2022 Jun 1;13(3):641-646. doi: 10.14336/AD.2021.1120. eCollection 2022 Jun.
2
COVID-19 vaccine breakthrough infections.
Science. 2021 Dec 24;374(6575):1561-1562. doi: 10.1126/science.abl8487. Epub 2021 Dec 23.
3
Omicron likely to weaken COVID vaccine protection.
Nature. 2021 Dec;600(7889):367-368. doi: 10.1038/d41586-021-03672-3.
4
COVID-19 vaccines for children.
Science. 2021 Nov 19;374(6570):913. doi: 10.1126/science.abn2566. Epub 2021 Nov 18.
5
Elderly Patient Care: A New Reality of the SARS-CoV-2 Pandemic.
Aging Dis. 2021 Oct 1;12(7):1554-1566. doi: 10.14336/AD.2021.0222. eCollection 2021 Oct.
6
Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary.
J Infect. 2021 Nov;83(5):559-564. doi: 10.1016/j.jinf.2021.08.031. Epub 2021 Aug 23.
7
COVID-19 vaccine equity and booster doses.
Lancet Infect Dis. 2021 Sep;21(9):1193. doi: 10.1016/S1473-3099(21)00486-2. Epub 2021 Aug 13.
8
Predictors of Vaccine Hesitancy: Implications for COVID-19 Public Health Messaging.
Int J Environ Res Public Health. 2021 Jul 29;18(15):8054. doi: 10.3390/ijerph18158054.
9
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.
Nature. 2021 Aug;596(7871):276-280. doi: 10.1038/s41586-021-03777-9. Epub 2021 Jul 8.
10
Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects.
Vaccines (Basel). 2021 May 26;9(6):556. doi: 10.3390/vaccines9060556.
Zotero 插件